140 related articles for article (PubMed ID: 37406274)
1. Detecting undetectable - epidemiology, etiology, and diagnosis of carcinoma of unknown primary - systematic review.
Ostojewska J; Wieczorek I; Pachciński O; Zdziennicki W; Burdan F
Folia Med Cracov; 2023 Apr; 63(1):19-37. PubMed ID: 37406274
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Site: New Routes to Targeted Therapies.
Ross JS; Wang K; Gay L; Otto GA; White E; Iwanik K; Palmer G; Yelensky R; Lipson DM; Chmielecki J; Erlich RL; Rankin AN; Ali SM; Elvin JA; Morosini D; Miller VA; Stephens PJ
JAMA Oncol; 2015 Apr; 1(1):40-49. PubMed ID: 26182302
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and management of carcinoma of unknown primary in the head and neck.
Issing WJ; Taleban B; Tauber S
Eur Arch Otorhinolaryngol; 2003 Sep; 260(8):436-43. PubMed ID: 12684829
[TBL] [Abstract][Full Text] [Related]
4. Carcinoma of unknown primary (CUP); some considerations about pathogenesis and diagnostic strategy, particularly focusing on CUPS pertaining to the Urology.
Alberti C
G Chir; 2012; 33(1-2):41-6. PubMed ID: 22357439
[TBL] [Abstract][Full Text] [Related]
5. Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary.
Han A; Xue J; Hu M; Zheng J; Wang X
Cancer Epidemiol; 2012 Oct; 36(5):470-5. PubMed ID: 22504050
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Origin: Retrospective Molecular Classification Considering the CUPISCO Study Design.
Ross JS; Sokol ES; Moch H; Mileshkin L; Baciarello G; Losa F; Beringer A; Thomas M; Elvin JA; Ngo N; Jin DX; Krämer A
Oncologist; 2021 Mar; 26(3):e394-e402. PubMed ID: 33219618
[TBL] [Abstract][Full Text] [Related]
7. Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities.
Regelink G; Brouwer J; de Bree R; Pruim J; van der Laan BF; Vaalburg W; Hoekstra OS; Comans EF; Vissink A; Leemans CR; Roodenburg JL
Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1024-30. PubMed ID: 12173016
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and management of metastatic neoplasms with unknown primary.
Bochtler T; Löffler H; Krämer A
Semin Diagn Pathol; 2018 May; 35(3):199-206. PubMed ID: 29203116
[TBL] [Abstract][Full Text] [Related]
9. FDG PET and PET/CT for the detection of the primary tumour in patients with cervical non-squamous cell carcinoma metastasis of an unknown primary.
Paul SA; Stoeckli SJ; von Schulthess GK; Goerres GW
Eur Arch Otorhinolaryngol; 2007 Feb; 264(2):189-95. PubMed ID: 17177026
[TBL] [Abstract][Full Text] [Related]
10. Cancer of unknown primary origin: a decade of experience in a community-based hospital.
Pimiento JM; Teso D; Malkan A; Dudrick SJ; Palesty JA
Am J Surg; 2007 Dec; 194(6):833-7; discussion 837-8. PubMed ID: 18005780
[TBL] [Abstract][Full Text] [Related]
11. [Cancer of unknown primary (CUP)-single-site, oligometastatic, and in the head and neck region].
Pouyiourou M; Regnery S; Bochtler T; Herfarth K; Krämer A
Radiologie (Heidelb); 2023 May; 63(5):358-365. PubMed ID: 36944857
[TBL] [Abstract][Full Text] [Related]
12. Head and neck cancer: carcinoma of unknown primary.
Donta TS; Smoker WR
Top Magn Reson Imaging; 2007 Aug; 18(4):281-92. PubMed ID: 17893593
[TBL] [Abstract][Full Text] [Related]
13. [Advances in the diagnosis of unknown primary carcinoma of the neck].
Kruk-Zagajewska A; Milecki P; Wierzbicka M
Otolaryngol Pol; 2005; 59(1):77-83. PubMed ID: 15915923
[TBL] [Abstract][Full Text] [Related]
14. [Radiological diagnostics in CUP syndrome].
Kazmierczak PM; Nikolaou K; Rominger A; Graser A; Reiser MF; Cyran CC
Radiologe; 2014 Feb; 54(2):117-23. PubMed ID: 24500247
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus and cystic node metastasis in oropharyngeal cancer and cancer of unknown primary origin.
Yasui T; Morii E; Yamamoto Y; Yoshii T; Takenaka Y; Nakahara S; Todo T; Inohara H
PLoS One; 2014; 9(4):e95364. PubMed ID: 24752007
[TBL] [Abstract][Full Text] [Related]
16. Evidence for the approach to the diagnostic evaluation of squamous cell carcinoma occult primary tumors of the head and neck.
Golusinski P; Di Maio P; Pehlivan B; Colley S; Nankivell P; Kong A; Hartley A; Mehanna H
Oral Oncol; 2019 Jan; 88():145-152. PubMed ID: 30616785
[TBL] [Abstract][Full Text] [Related]
17. Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy.
Miller FR; Karnad AB; Eng T; Hussey DH; Stan McGuff H; Otto RA
Head Neck; 2008 Jan; 30(1):28-34. PubMed ID: 17657782
[TBL] [Abstract][Full Text] [Related]
18. [Cancer of unknown primary site origin--advances in diagnosis and therapy].
Plot L; Dovrish Z; Hadari R; Weisenberg N; Zehavi T; Nisenbaum B; Amital H
Harefuah; 2008 Apr; 147(4):294-8, 376, 375. PubMed ID: 18686808
[TBL] [Abstract][Full Text] [Related]
19. 2[F]-fluoro-2-deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation.
Jungehülsing M; Scheidhauer K; Damm M; Pietrzyk U; Eckel H; Schicha H; Stennert E
Otolaryngol Head Neck Surg; 2000 Sep; 123(3):294-301. PubMed ID: 10964310
[TBL] [Abstract][Full Text] [Related]
20. Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites.
Sadowski SM; Neychev V; Millo C; Shih J; Nilubol N; Herscovitch P; Pacak K; Marx SJ; Kebebew E
J Clin Oncol; 2016 Feb; 34(6):588-96. PubMed ID: 26712231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
